Anupam Rasayan India

Anupam Rasayan India Equity

The The Equity of Anupam Rasayan India (ANURAS.NS) as of Oct 24, 2026 is 33.34 B INR. In the previous year, The Equity was 28.50 B INR — a change of 16.96% (higher).

Equity

33.34 BINR

YoY

16.96%

Last updated:

In 2026, Anupam Rasayan India's equity was 33.34 B INR, a 16.96% increase from the 28.50 B INR equity in the previous year.

The Anupam Rasayan India Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
5.07 B INR
Jan 1, 2020
5.94 B INR
Jan 1, 2021
15.73 B INR
Jan 1, 2022
17.27 B INR
Jan 1, 2023
23.73 B INR
Jan 1, 2024
27.61 B INR
Jan 1, 2025
28.50 B INR
Jan 1, 2026
33.34 B INR
The Anupam Rasayan India Equity history
YEAREquityYoY
33.34 BINR+16.96%
28.50 BINR+3.23%
27.61 BINR+16.37%
23.73 BINR+37.39%
17.27 BINR+9.75%
15.73 BINR+165.01%
5.94 BINR+17.08%
5.07 BINR+10.81%
4.58 BINR+83.31%
2.50 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Anupam Rasayan India Stock analysis

What does Anupam Rasayan India do? Anupam Rasayan India Ltd. generates revenue through manufacturing life science related specialty chemicals and other specialty chemicals. The company's Life Science Related Specialty Chemicals segment produces agro intermediates and agro active ingredients for insecticides, fungicides, and herbicides in the agrochemicals industry. It also supplies anti-bacterial and ultraviolet protection intermediates for the personal care industry, and intermediates for active pharmaceutical ingredients in the pharmaceutical segment. The Other Specialty Chemicals segment provides specialty pigments, specialty dyes, and polymer additives for diverse end-user applications. The company sells these products to manufacturers in the agrochemicals, personal care, and pharmaceutical industries, as well as to end-users requiring specialty chemicals for various applications. The company's product portfolio includes agro intermediates, agro active ingredients, anti-bacterial intermediates, ultraviolet protection intermediates, pharmaceutical intermediates, specialty pigments, specialty dyes, and polymer additives. These products are sold to industrial clients across multiple sectors, including agrochemicals, personal care, and pharmaceuticals. The Life Science Related Specialty Chemicals segment is the primary revenue driver, focusing on high-value chemical products for life science applications. The Other Specialty Chemicals segment supports the company's diversified revenue streams with products used in various industrial applications. Anupam Rasayan India Ltd. targets manufacturers within the agrochemicals industry for its agrochemical-related products, personal care brands for its personal care intermediates, and pharmaceutical companies for its pharmaceutical intermediates. The company's business model relies on supplying specialized chemical products to these specific industry segments, leveraging its manufacturing capabilities to serve the needs of clients in life science and specialty chemical markets. Anupam Rasayan India is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Anupam Rasayan India's Equity

Anupam Rasayan India's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Anupam Rasayan India's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Anupam Rasayan India's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Anupam Rasayan India's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Anupam Rasayan India’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Anupam Rasayan India stock

The Equity of Anupam Rasayan India is 33.34 B INR in 2026.

The Equity of Anupam Rasayan India changed from 28.50 B INR to 33.34 B INR, representing a 16.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Anupam Rasayan India since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Anupam Rasayan India historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Anupam Rasayan India

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Anupam Rasayan India